Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_66720d4d9c263c59a0a4f153a2651c98 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-241 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-24 |
filingDate |
2005-04-11^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81014a7549c056a4bd011538292fc97d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8eb6d14ac653183fd0b861ca7197c633 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_508b2bd08f676abc23d073bb3ee5f02a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_059303dd122d73caf5774e8421486d45 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3cb564c7bd0087fce85a344485eadfa |
publicationDate |
2007-01-23^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
MX-PA06011677-A |
titleOfInvention |
MULTIPLE VARIABLE DOSAGE REGIME TO TREAT DISORDERS RELATED TO THE TUMOR NECROSIS-ALFA FACTOR (TNFA). |
abstract |
Multiple-variable dosage methods for treating TNF-related disorders (including Crohn's disease and psoriasis, comprising administering TNF inhibitors (including TNF antibodies) are described. Multiple-variable dosage methods include administration of a TNF inhibitor in an induction or charge phase followed by administration of the agent in a maintenance or treatment phase, where the TNF inhibitor is administered at a higher dosage during the induction phase. |
priorityDate |
2004-04-09^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |